Kirsty Sawicka

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 9

Top Topics

Metastatic Breast Cancer

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Caryn R Hale, Kirsty Sawicka, Kevin Mora, John J Fak, Jin Joo Kang, Paula Cutrim, Katarzyna Cialowicz, Thomas S Carroll, Robert B Darnell
FMRP regulates mRNAs encoding distinct functions in the cell body and dendrites of CA1 pyramidal neurons. eLife 10 (2021)
Kirsty Sawicka, Caryn R Hale, Christopher Y Park, John J Fak, Jodi E Gresack, Sarah J Van Driesche, Jin Joo Kang, Jennifer C Darnell, Robert B Darnell
FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory. eLife 8 (2019)